|Last Price||Today's Change||52-Week Range||Trading Volume|
|29.39||0.01 (+0.03%)||27.86 - 32.96||16.8 million (Below Avg)|
Market data as of 4:00PM 08/29/14. Quotes are delayed by at least 15 min.
Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE)
08/30/2014 5:15 AM ET
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
08/28/2014 1:15 PM ET